Echo IQ Limited (ASX:EIQ) (OTCMKTS:ECHQF) use the AI-powered technology in EchoSolv to enhance the diagnosis of structural heart disease. Our mission is to help improve the lives of people by supporting earlier, more accurate detection of a number of life-threatening but often treatable conditions.



